文献
J-GLOBAL ID:201702238239633763
整理番号:17A1497276
新規GLP-1/GIP二重作動薬は炎症を低減し,パーキンソン病のMPTPマウスモデルにおけるGDNF放出を増強するリラグルチドよりも効果的である【Powered by NICT】
A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson’s disease
著者 (8件):
Yuan Ziyue
(Neurology Department, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China)
,
Li Dongfang
(Neurology Department, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China)
,
Feng Peng
(Neurology Department, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China)
,
Xue Guofang
(Neurology Department, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China)
,
Ji Chenhui
(Neurology Department, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China)
,
Li Guanglai
(Neurology Department, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China)
,
Holscher Christian
(Neurology Department, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China)
,
Holscher Christian
(Division of Biomed and Life Sciences, Faculty of Health and Medicine Lancaster University, Lancaster LA1 4YQ, UK)
資料名:
European Journal of Pharmacology
(European Journal of Pharmacology)
巻:
812
ページ:
82-90
発行年:
2017年
JST資料番号:
B0841A
ISSN:
0014-2999
CODEN:
EJPHAZ
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)